China Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. The Company through our indirect majority-owned People�s Republic of China subsidiaries, Shandong Taibang Biological Products Co. Ltd. (Shandong Taibang) and Guizhou Taibang Biological Products Co., Ltd. (Guizhou Taibang), and its minority-owned People�s Republic of China investee, Xi�an Huitian Blood Products Co., Ltd (Huitian), principally engaged in the research, development, manufacturing and sales of human plasma-based pharmaceutical products in China. The Company is approved to sell human albumin with dosages of 20%/10 milliliters, 20%/25 milliliters, 20%/50 milliliters, 10%/10 milliliters, 10%/25 milliliters, 10%/50 milliliters and 25%/50 milliliters. The Company sells its products to customers in the People�s Republic of China, mainly hospitals and inoculation centers directly or through approved distributors.